<DOC>
	<DOC>NCT00435461</DOC>
	<brief_summary>The primary objective of this study is to compare the nighttime symptom relief of fluticasone furoate nasal spray and oral fexofenadine</brief_summary>
	<brief_title>Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis, Allergic</mesh_term>
	<mesh_term>Rhinitis, Allergic, Seasonal</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Fexofenadine</mesh_term>
	<mesh_term>Terfenadine</mesh_term>
	<criteria>Inclusion criteria: Informed consent. Outpatient. Females of childbearing potential must use appropriate contraception. Diagnosis of seasonal allergic rhinitis to mountain cedar. Adequate exposure to allergen. Able to comply with study procedures. Literate. Exclusion criteria: Significant concomitant medical condition. Use of corticosteroids, allergy medications, or other medication that affect allergic rhinitis Positive pregnancy test. Allergy to any component of the investigational product. Tobacco use Contact lens use Has chickenpox or measles or recent exposure Other clinical trial drug exposure in last 30 days Affiliation with clinic site</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>once daily</keyword>
	<keyword>mountain cedar</keyword>
	<keyword>fexofenadine</keyword>
	<keyword>allergic rhinitis</keyword>
	<keyword>fluticasone furoate</keyword>
</DOC>